August Drug Recalls
This article was originally published in The Gold Sheet
You may also be interested in...
Recall Roundup: tainted heparin, glass flakes, odorous bottles and more
Economically motivated adulteration, glass flakes in vials, out-of-specification transdermal patches, malodorous bottles and prefilled syringe sterility were among the more significant manufacturing quality issues leading to drug recalls in the past three months.
Amneal Eyes Avastin And Praises $120m Biosimilar Development Savings
Amneal is close to a filed pipeline of three biosimilar products in the US, while furthering ambitions in the complex generics and 505(b)(2) space, management told the virtual J.P. Morgan Healthcare Conference.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: